🐬
|
Arterial hypertension and cancer
A. Milan,
E. Puglisi,
L. Ferrari,
G. Bruno,
I. Losano,
F. Veglio
|
6 |
2014 |
6 🐬
|
🦁
|
Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy
12 auth.
G. Bruno,
S. Bringhen,
I. Maffei,
A. Iannaccone,
T. Crea,
A. Ravera,
...
A. Astarita,
F. Vallelonga,
M. Salvini,
F. Gay,
F. Veglio,
A. Milan
|
4 |
2019 |
4 🦁
|
🐜
|
Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy
10 auth.
A. Iannaccone,
G. Bruno,
A. Ravera,
F. Gay,
M. Salvini,
S. Bringhen,
...
L. Sabia,
E. Avenatti,
F. Veglio,
A. Milan
|
4 |
2018 |
4 🐜
|
🐜
|
Prevalence of proximal ascending aorta and target organ damage in hypertensive patients: the multicentric ARGO-SIIA project (Aortic RemodellinG in hypertensiOn of the Italian Society of Hypertension)
15 auth.
A. Milan,
D. Degli Esposti,
M. Salvetti,
R. Izzo,
A. Moreo,
G. Pucci,
G. Bruno,
I. Pareo,
A. Parini,
A. Paini,
...
F. I. Laurino,
P. Sormani,
R. Sgariglia,
E. Avenatti,
N. De Luca
|
4 |
2018 |
4 🐜
|
🐜
|
Prognostic role of the ascending aorta dilatation in patients with arterial hypertension
16 auth.
D. Leone,
L. Airale,
S. Bernardi,
G. Mingrone,
A. Astarita,
M. Cesareo,
L. Sabia,
E. Avenatti,
F. Tosello,
G. Bruno,
...
C. Catarinella,
V. Venturelli,
Carlo Giordana,
F. Veglio,
F. Vallelonga,
A. Milan
|
4 |
2021 |
4 🐜
|
🐜
|
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction
17 auth.
A. Astarita,
G. Mingrone,
L. Airale,
F. Vallelonga,
M. Covella,
C. Catarinella,
M. Cesareo,
G. Bruno,
D. Leone,
Carlo Giordana,
...
Giusy Cetani,
M. Salvini,
F. Gay,
S. Bringhen,
F. Rabbia,
F. Veglio,
A. Milan
|
3 |
2021 |
3 🐜
|
🐜
|
Left Heart Morphology and Function in Primary Aldosteronism
7 auth.
A. Milan,
C. Magnino,
A. Fabbri,
M. Chiarlo,
G. Bruno,
I. Losano,
...
F. Veglio
|
3 |
2012 |
3 🐜
|